🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology

Recruitingn/aAges 18 Years - 45 YearsFemaleIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06788821 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes in fetuses belonging to women with thyroid disease and women with low obstetric risk (i.e., pregnancy not complicated by maternal and/or fetal pathology) between 14 and 37 gestational weeks. The main question it aims to answer is: Is it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Participants between 14 and 37 gestational weeks, who will be followed for the entire period of pregnancy, up to delivery, at the same enrolling center * Obtaining informed consent for participation in the study * Maternal age between 18 and 45 years (extremes included) * Participants with good understanding of the Italian language Exclusion Criteria: * Smoking participants * Patients with BMI\>30 * Absence of correct dating of pregnancy within the first trimester * Pathological conditions (e.g., malabsorptive or socioeconomic conditions that may interfere with fetal growth) * Twin pregnancy * Only for the low obstetric risk group of patients: Fetus with malformative pathology
💊

What it tests

  • Description of the trend of major thyroid ultrasound biometric parameters
📍

Where

2 sites
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy
Ospedale Santa Chiara - Trento
Trento, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy